Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia - Evaluation of outcome

Citation
M. Ruiz et al., Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia - Evaluation of outcome, AM J R CRIT, 162(1), 2000, pp. 119-125
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","da verificare
Journal title
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN journal
1073449X → ACNP
Volume
162
Issue
1
Year of publication
2000
Pages
119 - 125
Database
ISI
SICI code
1073-449X(200007)162:1<119:NVIMII>2.0.ZU;2-3
Abstract
Noninvasive and invasive diagnostic techniques have been shown to achieve c omparable performances in the evaluation of suspected ventilator-associated pneumonia (VAP). We studied the impact of both approaches on outcome in a prospective, open, and randomized study in three intensive care units (ICUs ) of a 1,000-bed tertiary care university hospital. Patients with suspected VAP were randomly assigned to noninvasive (Group 1) versus invasive (Croup 2) investigation (tracheobronchial aspirates [TBAS] versus bronchoscopical ly retrieved protected specimen brush [PSB] and bronchoalveolar lavage [BAL ]. Samples were cultured quantitatively, and BAL fluid (BALF) was examined for intracellular organisms (ICO) additionally. Initial empiric antimicrobi al treatment was administered following the guidelines of the American Thor acic Society (ATS) and adjusted according to culture results land ICO count s in Group 2). Outcome variables included length of ICU stay and mechanical ventilation as well as mortality. Overall, 76 patients (39 noninvasive, 37 invasive) were investigated. VAP was microbiologically confirmed in 23 of 39 (59%) and 23 of 37 (62%) (p = 0.78). There were no differences with rega rd to the frequencies of community-acquired and potentially drug-resistant microorganisms (PDRM). Antimicrobial treatment was changed in seven patient s (18%) of Group 1 and 10 patients (27%) of Group 2 because of etiologic fi ndings (including five of 17 with ICO = 2% (p = not significant [NS]). Leng th of ICU stay and mechanical ventilation were also not significantly diffe rent in both groups. Crude 30-d mortality was 31 of 76 (41%), and 18 of 39 (46%) in Group 1 and 14 of 37 (38%) in Group 2 (p = 0.46). Adjusted mortali ty was 16% versus 11% (p = 0.53), and mortality of microbiologically confir med pneumonia 10 of 23 (44%) in both groups (p = 1.0). We conclude that the outcome of VAP was not influenced by the techniques used for microbial inv estigation.